Intradialytic Exercise on the Fatigue, Sleep Disorder, Arterial Stiffness and Endothelial Function in Uremic Patients

March 1, 2022 updated by: Buddhist Tzu Chi General Hospital

The Effect of Intradialytic Exercise on the Fatigue, Sleep Disorder, Arterial Stiffness and Endothelial Function in Uremic Patients

To determine the effect of intradialytic cycling exercise on fatigability, sleep disorders, arterial stiffness and endothelial function in dialysis patients

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The endothelium is a key regulator of vascular homeostasis and chronic exposure to vascular risk factors alters the regulatory properties of the endothelium, which progresses toward a pro-inflammatory pattern, senescence, and apoptosis. Endothelial cell integrity and function are critical to the prevention of atherosclerosis, and therefore endothelial cell injury and dysfunction are major steps in the development and progression of cardiovascular disease. Endothelial dysfunction may be the landmark of active disease process through the course of atherosclerotic cardiovascular disease, and a significant risk factor for future cardiovascular events.

Several studies had reported that not only medical treatment but also exercise could improve physical and vascular functions, dialytic efficiency, quality of sleep, fatigue and depression et al. Exercise could be classified to aerobic, Anaerobic exercise and resistance et. Several studies have shown that regular cycling exercise in hemodialysis patients could improve physical activity, sleep quality, and reduce fatigability. Therefore, exercise plays an important role in hemodialysis patients. According to these benefits, the investigator's study was designed to explore the effects of intradialytic cycling exercise on sleep quality and fatigability, adipokines and myokinins levels in hemodialysis patients.

Study Type

Interventional

Enrollment (Actual)

114

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hualien City, Taiwan
        • Buddhist Tzu Chi General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 75 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Regular hemodialysis more than 3 months with 4 hours a time, thrice a week
  • Eligible to sign permit

Exclusion Criteria:

  • Could not sign permit or do not want to join the trial
  • Infection
  • Amputation of any one of the lower limb
  • Hemodynamic unstable
  • Acute myocardial infarction (AMI) in recent 6 months
  • Unstable heart condition, such as unstable angina, arrythmia
  • Deep vein thrombosis (DVT)
  • History of kidney transplantation
  • Vascular access over lower limb

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Intradialytic exercise
Cycling exercise 30 minutes a time, three times a week during hemodialysis
Intradialytic cycling exercise for 30 minutes a time
NO_INTERVENTION: Control group
not participate in cycling exercise during hemodialysis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of the Functional Assessment of Chronic Illness Therapy -Fatigue (FACIT-F) score for 2 years
Time Frame: pre-test and then every 3 months for 2 years
Compare the FACIT-F score before, during and after intradialytic cycling exercise FACIT-F score is from 0-52 points; higher score represents less fatigue.
pre-test and then every 3 months for 2 years
Change of the Pittsburgh Sleep Quality Index (PSQI) score for 2 years
Time Frame: pre-test and then every 3 months for 2 years
Compare the PSQI score before, during and after intradialytic cycling exercise PSQI score is from 0-21 points; score>=5 means poor sleeping quality.
pre-test and then every 3 months for 2 years
Change of the carotid-femoral pulse wave velocity (cfPWV) for 2 years
Time Frame: pre-test and then every 3 months for 2 years

Compare the cfPWV before, during and after intradialytic cycling exercise

cfPWV measurement: a measure of aortic wall stiffness, increases markedly with age. Each set of pulse wave and ECG data to calculate the mean time difference between R-wave and pulse wave on a beat-to-beat basis, with an average of 10 consecutive cardiac cycles. The cfPWV will be calculated using the distance and mean time difference between the two recorded points.

Patients with cfPWV values of > 10 m/s were classified in the high arterial stiffness group, whereas those with cfPWV values of ≤10 m/s were assigned to the low arterial stiffness group.

pre-test and then every 3 months for 2 years
Change of the cardio-ankle vascular index (CAVI) for 2 years
Time Frame: pre-test and then every 3 months for 2 years

Compare the CAVI before, during and after intradialytic cycling exercise

CAVI is a novel and accurate method, independent of the effect of blood pressure, and is used as a predictor of arterial stiffness (AS) AS was defined as a CAVI ≥ 9

pre-test and then every 3 months for 2 years
Change of the brachial-ankle pulse wave velocity (baPWV) for 2 years
Time Frame: pre-test and then every 3 months for 2 years

Compare the baPWV before, during and after intradialytic cycling exercise

baPWV is one measure arterial stiffness using brachial to ankle arterial wave analyses and has been used to assess peripheral arterial stiffness (PAS)

baPWV value >14.0 m/s on either side was considered high PAS.

pre-test and then every 3 months for 2 years
Change of the aortic augmentation index(AI) measurements for 2 years
Time Frame: pre-test and then every 3 months for 2 years

Compare the AI before, during and after intradialytic cycling exercise

AI of central blood pressure have been widely used as clinical indices of arterial stiffness AI is an indirect measure of central arterial stiffness, but mainly a direct measure of central wave reflection

pre-test and then every 3 months for 2 years
Change of the brachial flow-mediated vasodilatation (bFMD) for 2 years
Time Frame: pre-test and then every 3 months for 2 years

Compare the bFMD before, during and after intradialytic cycling exercise

Endothelial function is often quantified by FMD, which represents the endothelium-dependent relaxation of a conduit artery-typically the brachial artery - due to an increased blood flow.

pre-test and then every 3 months for 2 years
Change of the digital thermal monitoring (DTM) for 2 years
Time Frame: pre-test and then every 3 months for 2 years

Compare the DTM before, during and after intradialytic cycling exercise

DTM is a simple noninvasive method to measure endothelial function and vascular reactivity that is correlated with atherosclerosis risk factors and coronary artery disease

Vascular reactivity index (VRI) < 1.0: the poor vascular reactivity, 1.0 ≤ VRI < 2.0: the intermediate vascular reactivity, and VRI ≥ 2.0: the good vascular reactivity.

pre-test and then every 3 months for 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yu-Hsien Lai, Attending Physician

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2018

Primary Completion (ACTUAL)

December 31, 2020

Study Completion (ACTUAL)

December 31, 2021

Study Registration Dates

First Submitted

September 15, 2019

First Submitted That Met QC Criteria

September 19, 2019

First Posted (ACTUAL)

September 23, 2019

Study Record Updates

Last Update Posted (ACTUAL)

March 2, 2022

Last Update Submitted That Met QC Criteria

March 1, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fatigue

Clinical Trials on Cycling exercise

3
Subscribe